Results 61 to 70 of about 3,922 (162)

Metabolic alterations associated with sacubitril/valsartan treatment: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Abhari AP, Rezvanian P, Rahmani AR, Fakhrolmobasheri M, Meraji Far F, Ostadsharif N, Adelparvar F.   +6 more
europepmc   +1 more source

The effects of sacubitril/valsartan compared to valsartan in experimentally induced chronic kidney disease. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Al Maskari R, Abdelrahman AM, Shalaby A, Manoj P, Al Suleimani YM.   +4 more
europepmc   +1 more source

Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey. [PDF]

ESC Heart Fail
Yaseen IF, Farhan HA, Gnanaraj JP, Fukaya H, Prameswari HS, Saldarriaga C, Kemaloğlu Öz T, Elhout SA, Díez-Villanueva P, Costanzo MR, Toma M, Elsheikh Ibrahim NOE, Dakhil ZA, Mewton N, Mullens W, IKNOW-HF investigators Group .   +15 more
europepmc   +1 more source

Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.

Proceedings of the National Academy of Sciences of the United States of America, 1999
R. Mihalek, P. Banerjee, E. Korpi, Joseph J. Quinlan, L. Firestone, Z. Mi, C. Lagenaur, V. Tretter, W. Sieghart, S. Anagnostaras, J. Sage, M. Fanselow, A. Guidotti, I. Spigelman, Zhiwei Li, T. Delorey, R. Olsen, G. Homanics   +17 more
semanticscholar   +1 more source

Sacubitril valsartan combined with bisoprolol reduces doxorubicin-induced cardiotoxicity in rats by attenuating oxidative stress. [PDF]

Exp Biol Med (Maywood)
Liu P, Yang H, Li R, Huang H, Xu M.
europepmc   +1 more source

C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report. [PDF]

BMC Nephrol
Yanagidani H, Maeoka Y, Yoshida M, Ueda M, Kumano M, Takahashi A, Okubo A, Kato N, Maruyama S, Masaki T.   +9 more
europepmc   +1 more source

Efficacy of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in right ventricular systolic dysfunction and preserved LV ejection fraction: A randomized clinical trial. [PDF]

Indian Heart J
Mathur R, Baroopal A, Chaudhary CR, Hakim A, Verma M.   +4 more
europepmc   +1 more source

4-Aminobutyrate (GABA): a metabolite and signal with practical significance

, 2017
B. Shelp, A. Bown, Adel Zarei
semanticscholar   +1 more source

Efficacy and safety of sacubitril/valsartan in patients on peritoneal dialysis: a systematic review and meta-analysis. [PDF]

J Bras Nefrol
Silva CLD, Fonseca PEO, Calice-Silva V, Ponce D, Rocha PN, Guimarães MG.   +5 more
europepmc   +1 more source

Efficacy and safety of sacubitril/valsartan combined with dapagliflozin in non-diabetic patients with advanced chronic kidney disease. [PDF]

Front Endocrinol (Lausanne)
Wang H, Li X, Jiang C, Liu X.
europepmc   +1 more source